406 POSTER IMC-18F1, a recombinant human monoclonal antibody (MAb) against the vascular endothelial growth factor receptor-1 (VEGFR-1), in the treatment of patients (pts) with advanced solid malignancies: A Phase 1 study
S. Krishnamurthi, P.H.B. Goncalves, F. Fox, N. Hall, E. Rowinsky, J. Schwartz, H. Youssoufian, P. LoRussoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72340-1
File:
PDF, 81 KB
english, 2008